REGIMENTED PHOSPHODIESTERASE TYPE 5 INHIBITOR USE REDUCES EMERGENCY DEPARTMENT VISITS FOR RECURRENT ISCHEMIC PRIAPISM

被引：0
|
作者：
Hou, L. [1 ]
Burnett, A. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2021年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
122
引用
收藏
页码：S64 / S65
页数：4
相关论文
共 50 条
  • [1] Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism REPLY
    不详
    JOURNAL OF UROLOGY, 2021, 205 (02): : 553 - 553
  • [2] Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism EDITORIAL COMMENTS
    Montague, Drogo K.
    JOURNAL OF UROLOGY, 2021, 205 (02): : 552 - 553
  • [3] EMERGENCY ROOM VISITS ARE REDUCED IN PATIENTS USING TYPE 5 PHOSPHODIESTERASE INHIBITORS FOR RECURRENT PRIAPISM
    Rajih, E.
    Campbell, J.
    Burnett, A. L.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S205 - S205
  • [4] Daily Phosphodiesterase Type 5 Inhibitor Therapy as Rescue for Recurrent Ischemic Priapism After Failed
    Pierorazio, Phillip M.
    Bivalacqua, Trinity J.
    Burnett, Arthur L.
    JOURNAL OF ANDROLOGY, 2011, 32 (04): : 371 - 374
  • [5] Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism
    Nardozza Junior, Archimedes
    Cabrini, Marcelo Rodrigues
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (08): : 689 - 692
  • [6] Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism
    Burnett, Arthur L.
    Bivalacqua, Trinity J.
    Champion, Hunter C.
    Musicki, Biljana
    JOURNAL OF SEXUAL MEDICINE, 2006, 3 (06): : 1077 - 1084
  • [7] Re: Feasibility of the use of phosphodiesterase type 5 inhibitors in a Pharmacologic prevention program for recurrent priapism
    Burnett, A. L.
    Bivalacqua, T. J.
    Champion, H. C.
    Musicki, B.
    EUROPEAN UROLOGY, 2007, 52 (03) : 918 - 919
  • [8] Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism
    Burnett, AL
    Bivalacqua, TJ
    Champion, HC
    Musicki, B
    UROLOGY, 2006, 67 (05) : 1043 - 1048
  • [9] Long-term oral phosphodiesterase-5 inhibitor therapy alleviates recurrent priapism
    Burnett, AL
    Bivalacqua, TJ
    Champion, HC
    Musicki, B
    JOURNAL OF UROLOGY, 2006, 175 (04): : 301 - 301
  • [10] Phosphodiesterase Type 5 Inhibitor Use and Hearing Impairment
    McGwin, Gerald, Jr.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 136 (05) : 488 - 492
12345